NN Inc. Up 5 Percent With No Identifiable Catalyst
NN, Inc. rose 5.3% to $3.18 on July 20, and the sources Sort Brick tracks did not explain the move.
What's happening
NN, Inc. shares rose 5.3% to $3.18 on July 20. The sources Sort Brick tracks did not explain the move: the coverage collected that day named other companies, and none of it covered NN, Inc.
The numbers
The price on the story day was $3.18, up 5.3%. Chatter: zero relevant signals.
Our read
No identifiable catalyst. A 5% move with zero news in a small-cap manufacturer can reflect a technical bounce, sector rotation, or thin-volume trading. Without a filing, analyst note, or operational announcement tied to NNBR, this is not a signal worth acting on.
Context
No price history for NN, Inc. is in this set, so the July 20 price cannot be placed in a 30- or 90-day range. Earlier Sort Brick stories on the company are dated July 17, 18 and 19, 2026. Each reported a gain of about 5% with no identifiable catalyst and was rated quiet, so the 5.3% move on July 20 is similar in kind to those. Later stories, dated July 21, 24 and 25, 2026, are also rated quiet, and the July 21 story reports a 9% climb. Chatter on the story day registered zero signals. Without after-day price rows, this story cannot say how the stock traded in the days that followed.
Sources we checked
- Analyst Report: United Airlines Holdings Inc β finance.yahoo.com
- Analyst Report: Goldman Sachs Group Inc/The β finance.yahoo.com
- Hereβs Why Happen Incβs (HAPN) Rebranding Could Mean More Than Investors Think β finance.yahoo.com
- Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? β finance.yahoo.com
- Is AtaiBeckley Inc. (ATAI) Stock a Psychedelic Medicine Opportunity Ahead of Phase 2 Results? β finance.yahoo.com
- Is Definium Therapeutics, Inc. (DFTX) Stock a Biotech Opportunity After Positive DT120 Depression Trial Data? β finance.yahoo.com
- Is Vistagen Therapeutics, Inc. (VTGN) Stock Facing New Challenges After PALISADE-4 Clinical Trial Results? β finance.yahoo.com
- Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? β finance.yahoo.com
See today's live board
This story is frozen as published on July 20, 2026. The live board shows what is moving right now, scored against real money.
Open this story live β See today's live boardEarlier on NN, Inc. (NNBR)
- NN Inc. Up 5% With No Identifiable Catalyst July 19, 2026
- NN Inc. Gains 5% With No Catalyst in Sight July 18, 2026
- NN Inc. Rises 5% With No Visible Catalyst or Chatter July 17, 2026
More Stocks stories
- Microsoft Trains Sales Team to Undercut OpenAI and Anthropic July 20, 2026
- FAA Restores Boeing Certification While 777X Gets Scrapped July 20, 2026
- AST SpaceMobile Climbs 5 Percent as Launch Window Nears July 20, 2026
- Lucid Denies Bankruptcy as LCID Surges 14 Percent July 20, 2026
- Google Earnings Due Wednesday Amid EU Mandate and AI Reshuffling July 20, 2026
- Apple Sues OpenAI and Wins China AI Approval in Same Week July 20, 2026
Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything β you decide.